Your browser is no longer supported. Please, upgrade your browser.
Settings
MRK Merck & Co., Inc. daily Stock Chart
MRK [NYSE]
Merck & Co., Inc.
IndexDJIA S&P500 P/E20.34 EPS (ttm)3.98 Insider Own0.10% Shs Outstand2.53B Perf Week4.63%
Market Cap204.77B Forward P/E13.41 EPS next Y6.03 Insider Trans-4.24% Shs Float2.52B Perf Month4.08%
Income10.20B PEG3.39 EPS next Q1.08 Inst Own77.60% Short Float0.75% Perf Quarter2.16%
Sales48.08B P/S4.26 EPS this Y58.90% Inst Trans-1.03% Short Ratio1.43 Perf Half Y-7.27%
Book/sh10.35 P/B7.81 EPS next Y13.28% ROA12.10% Target Price93.94 Perf Year0.72%
Cash/sh2.93 P/C27.55 EPS next 5Y6.00% ROE38.10% 52W Range65.25 - 92.64 Perf YTD-11.12%
Dividend2.44 P/FCF65.44 EPS past 5Y-1.10% ROI19.20% 52W High-12.74% Beta0.50
Dividend %3.02% Quick Ratio0.90 Sales past 5Y2.10% Gross Margin72.20% 52W Low23.89% ATR1.99
Employees71000 Current Ratio1.10 Sales Q/Q11.50% Oper. Margin25.50% RSI (14)58.29 Volatility2.41% 2.27%
OptionableYes Debt/Eq1.07 EPS Q/Q10.30% Profit Margin21.10% Rel Volume0.81 Prev Close79.56
ShortableYes LT Debt/Eq0.83 EarningsApr 28 BMO Payout58.30% Avg Volume13.29M Price80.84
Recom1.90 SMA203.77% SMA503.62% SMA200-2.90% Volume10,760,713 Change1.61%
Feb-27-20Initiated Barclays Overweight $93
Jan-07-20Initiated RBC Capital Mkts Sector Perform $99
Oct-17-19Resumed BofA/Merrill Neutral $90
Aug-16-19Initiated SVB Leerink Outperform
Jul-03-19Initiated Mizuho Buy $97
May-28-19Initiated Goldman Neutral
May-13-19Upgrade Atlantic Equities Neutral → Overweight
Oct-16-18Reiterated Citigroup Buy $70 → $79
Oct-09-18Resumed Guggenheim Buy
Apr-23-18Upgrade Goldman Neutral → Buy
Apr-17-18Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-05-18Upgrade Barclays Equal Weight → Overweight $62 → $64
Mar-12-18Upgrade Leerink Partners Mkt Perform → Outperform
Feb-14-18Reiterated Leerink Partners Mkt Perform $67 → $66
Feb-07-18Reiterated Morgan Stanley Equal-Weight $60 → $63
Jan-16-18Upgrade SunTrust Hold → Buy
Nov-28-17Resumed BofA/Merrill Buy $64
Nov-24-17Reiterated Deutsche Bank Hold $62 → $59
Oct-31-17Upgrade Jefferies Underperform → Hold
Oct-30-17Downgrade SunTrust Buy → Hold
Jun-02-20 02:50PM  
11:33AM  
10:53AM  
09:16AM  
Jun-01-20 03:06PM  
12:18PM  
11:26AM  
09:07AM  
06:45AM  
02:15AM  
May-31-20 05:32PM  
May-30-20 09:25AM  
May-29-20 01:36PM  
11:35AM  
10:57AM  
08:28AM  
07:22AM  
06:00AM  
May-28-20 06:37PM  
05:00PM  
02:56PM  
01:56PM  
11:34AM  
11:30AM  
10:56AM  
09:53AM  
06:26AM  
05:37AM  
May-27-20 10:49AM  
03:38AM  
May-26-20 04:58PM  
04:42PM  
04:35PM  
04:34PM  
04:30PM  
04:08PM  
04:00PM  
02:45PM  
02:30PM  
01:53PM  
01:47PM  
01:12PM  
01:09PM  
12:37PM  
12:06PM  
11:53AM  
11:43AM  
10:48AM  
10:48AM  
09:59AM  
09:54AM  
09:49AM  
09:38AM  
09:33AM  
09:22AM  
09:22AM  
07:58AM  
07:44AM  
07:26AM  
06:51AM  
06:49AM  
06:49AM  
06:47AM  
06:45AM  
06:45AM  
May-24-20 02:40PM  
May-22-20 07:46AM  
May-21-20 03:48PM  
02:24PM  
May-20-20 09:23AM  
09:02AM  
07:58AM  
07:05AM  
06:55AM  
06:26AM  
May-19-20 03:18PM  
03:15PM  
02:14PM  
01:16PM  
01:04PM  
11:53AM  
10:33AM  
07:00AM  
May-18-20 02:54PM  
02:47PM  
May-15-20 03:13PM  
03:09PM  
02:54PM  
May-14-20 02:47PM  
02:15PM  
01:46PM  
10:46AM  
08:44AM  
06:55AM  
06:45AM  
May-13-20 05:03PM  
05:00PM  
05:00PM  
05:00PM  
05:00PM  
Merck & Co., Inc. provides healthcare solutions worldwide. It operates through Pharmaceutical and Animal Health segments. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; and Skyhawk Therapeutics, Inc. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRUN LESLIE ADirectorMay 07Option Exercise0.005,00006,948May 07 04:48 PM
WEEKS WENDELL PDirectorMay 07Option Exercise0.005,00005,100May 07 04:50 PM
BRUN LESLIE ADirectorMay 07Sale75.465,000377,3001,948May 07 04:48 PM
WEEKS WENDELL PDirectorMay 07Sale76.025,000380,104100May 07 04:50 PM
Nally MichaelEVP, Chief Marketing OfficerMay 05Option Exercise76.862,345180,23712,054May 06 05:14 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 05Option Exercise76.863,283252,33129,401May 06 05:15 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 05Option Exercise76.861,29099,1497,304May 06 05:16 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 05Option Exercise76.863,752288,37982,611May 06 05:17 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 04Option Exercise77.671,904147,88479,797May 06 05:17 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 04Option Exercise77.6769253,7486,252May 06 05:16 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise77.671,21294,13626,715May 06 05:15 PM
Zachary JenniferEVP, General CounselMay 04Option Exercise77.675,772448,3119,489May 06 05:13 PM
Nally MichaelEVP, Chief Marketing OfficerMay 04Option Exercise77.671,298100,81610,274May 06 05:14 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 03Option Exercise77.6787567,96125,934May 05 04:48 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 03Option Exercise77.671,541119,6896,089May 05 04:42 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJan 13Option Exercise0.0082,5480139,111Jan 15 05:15 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJan 13Sale89.34102,0739,118,86537,038Jan 15 05:15 PM
Nally MichaelEVP, Chief Marketing OfficerOct 30Option Exercise0.002,28706,196Nov 01 05:07 PM
MIZELL STEVENEVP, Chief HR OfficerOct 30Option Exercise0.004,57404,574Nov 01 05:07 PM
Clyburn FrankEVP, Chief Commercial OfficerOct 30Option Exercise0.002,287073,032Nov 01 05:06 PM
Scholefield James HEVP,Chief Info&Digital OfficerOct 30Option Exercise0.0011,436011,436Nov 01 05:04 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 09Option Exercise0.006,427077,951Aug 12 05:13 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 09Sale85.096,427546,85071,524Aug 12 05:13 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 08Option Exercise0.0031,6990103,223Aug 12 05:13 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 08Sale85.0131,6992,694,78971,524Aug 12 05:13 PM
Davis Robert MEVP, Global Svcs & CFOJun 25Option Exercise0.00216,7180354,378Jun 27 05:05 PM
Davis Robert MEVP, Global Svcs & CFOJun 25Sale85.43216,71818,514,032137,660Jun 27 05:05 PM